UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2008
                               --------------

[_]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934

For the Transition Period from __________ to __________

Commission File No. 000-52910

                            CENTRACAN INCORPORATED
               (Name of Small Business Issuer in Its Charter)

                  Florida                                    65-0736042
----------------------------------------------           -----------------
         (State or Other Jurisdiction               (I.R.S. Employer
         of Incorporation or Organization)                  Identification No.)

c/o Olshan Grundman Frome et al.
65 East 55th Street, New York, New York                             10022
--------------------------------------------------             ---------------
         (Address of Principal Executive Offices)                 (Zip Code)

Issuer's telephone number, including area code:      (212) 451-2254


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of  the  Exchange Act  of  1934   during  the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been  subject to such filing requirements for
the past 90 days.                                   Yes [  ] No [X]

Indicate  by  check  mark  whether the registrant is a large accelerated  filer,
an  accelerated  filer, a non-accelerated filer, or a smaller reporting company.

         Large accelerated filer [  ]         Accelerated filer [  ]

         Non-accelerated filer [  ]           Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined  in
Rule12b-2 of the Exchange Act).                     Yes [X] No [  ]

As of March 31, 2008, there were 392,457 shares of common stock outstanding.

                                      1


<PAGE>


                             CENTRACAN INCORPORATED
           FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2008

                               TABLE OF CONTENTS


                    PART I                                                  Page

Item 1.             FINANCIAL STATEMENTS                                      3

Item 2.             MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF
                    OPERATION                                                11

Item 4T.            CONTROLS AND PROCEDURES                                  14

                    PART II

Item 1.             LEGAL PROCEEDINGS                                        14

Item 2.             UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
                    PROCEEDS                                                 14

Item 3.             DEFAULTS UPON SENIOR SECURITIES                          14

Item 4.             SUBMISSION OF MATTERS TO A VOTE OF SECURITIY HOLDERS     14

Item 5.             OTHER INFORMATION                                        15

Item 6.             EXHIBITS                                                 15

SIGNATURES                                                                   15

EXHIBITS

                                      2


<PAGE>


                                    PART I

Item 1.  Financial Statements.


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

FINANCIAL STATEMENTS
FINANCIAL STATEMENTS AS OF MARCH 31, 2008 AND
DECEMBER 31, 2007 AND FOR THE THREE MONTHS ENDED
MARCH 31, 2008 AND 2007 AND FOR THE PERIOD MARCH 21, 1997


                                       3
<PAGE>


CENTRACAN, INC.
(A Development Stage Company)


TABLE OF CONTENTS
--------------------------------------------------------------------------------

FINANCIAL STATEMENTS AS OF MARCH 31, 2008 AND DECEMBER 31, 2007 AND FOR THE
THREE MONTHS ENDED MARCH 31, 2008 AND 2007 AND FOR THE PERIOD MARCH 21, 1997
(DATE OF INCEPTION) THROUGH MARCH 31, 2008

Balance sheets                                                                5

Statements of operations                                                      6

Statements of cash flows                                                     7-8





                                       4
<PAGE>


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEETS
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>

                                                   UNAUDITED
ASSETS                                               MARCH         DECEMBER 31,
                                                     2008              2007
                                                  -------------   -------------
<S>                                                <C>             <C>
CURRENT ASSETS:

  Cash                                             $          9    $         84
                                                  -------------    -------------
  Total current assets                                        9              84
                                                  -------------    -------------
TOTAL ASSETS                                       $          9    $         84
                                                  =============    =============

LIABILITIES AND STOCKHOLDERS' DEFICIENCY


CURRENT LIABILITIES:

  Accounts payable and accrued expenses            $    109,823    $    105,308

  Notes payable - related party                          61,759          61,009
                                                  -------------    -------------
  Total current liabilities                             171,582         166,317
                                                  -------------    -------------
STOCKHOLDERS' DEFICIENCY:

  Preferred stock, par value $.0001 per
   share; 10,000,000 shares authorized;
   none issued and outstanding                              --               --
   as of June 30, 2007 and December
   31, 2006, respectively
  Common stock, par value $.0001 per
   share; 50,000,000
   shares authorized; 392,457 shares
   issued and outstanding                                   40               40
   as of June 30, 2007 and December 31, 2006,
   respectively
  Additional paid-in capital                           137,008          137,008
  Deficit accumulated during the development
  stage                                               (308,621)        (303,281)
                                                  -------------    -------------
    Total stockholders' deficiency                    (171,573)        (166,233)
                                                  -------------    -------------
    TOTAL LIABILITIES AND STOCKHOLDERS'
    DEFICIENCY                                     $          9    $         84
                                                   ============    =============
</TABLE>


   The accompanying notes are an integral part of these financial statements.


                                       5
<PAGE>


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>

                                                 THREE MONTHS ENDED                           FOR THE PERIOD
                                                      MARCH  31,                              MARCH 21, 1997
                                                                                          (DATE OF INCEPTION) TO
                                                 2008            2007                         MARCH 31, 2008
                                             -------------  -------------                  --------------------
<S>                                            <C>            <C>                           <C>
DEVELOPMENT STAGE REVENUES                     $         0    $         0                   $            24,728

DEVELOPMENT STAGE EXPENSES:

        Accounting and Auditing                      1,500              0                               122,371
        Advertising                                      0              0                                30,560
        Bank charges                                    75              0                                 1,005
        Consulting fees                                  0              0                                 5,082
        Legal fees                                       0              0                                48,947
        Licenses and taxes                             200                                                2,782
        Meals and entertainment                          0              0                                 5,248
        Miscellanous expenses                            0              0                                 1,828
        Office general                                   0              0                                 8,928
        Payroll and commissions                          0              0                                14,430
        Shareholder related services (EDGAR )         1424              0                                 3,959
        Transfer agent fees                            888            200                                19,895
                                             -------------  -------------                  --------------------
TOTAL DEVELOPMENT STAGE EXPENSES                     4,087            200                               265,035
                                             -------------  -------------                  --------------------
        LOSS FROM OPERATIONS                        (4,087)          (200)                             (240,307)

        LOSS ON INVESTMENT - HEALTHCARE                  0              0                               (50,016)

        INTEREST EXPENSE                            (1,553)        (1,137)                              (18,298)
                                             -------------  -------------                  --------------------

        NET LOSS                               $    (5,640)   $    (1,337)                  $          (308,621)
                                             =============  =============                  ====================
LOSS PER COMMON SHARE
        Basic & diluted                        $     (0.01)   $     (0.00)
                                             =============  =============
Weighted-average number of common
shares outstanding                                 392,457        392,457
                                             =============  =============
</TABLE>


   The accompanying notes are an integral part of these financial statements.


                                       6
<PAGE>


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOWS
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>

                                                               THREE MONTHS ENDED                   FOR THE PERIOD
                                                                   MARCH  31,                       MARCH 21, 1997
                                                                                                  (DATE OF INCEPTION)
OPERATING ACTIVITIES                                          2008            2007                 TO MARCH  31, 2008
                                                          -------------  -------------            -------------------
<S>                                                        <C>            <C>                      <C>
Net loss                                                   $     (5,340)  $     (1,337)            $         (308,621)

Adjustment to reconcile net loss to net cash
used by operations
        Shares issued for consulting services                         0              0                         36,148
        Shares issued for termination of HMC                          0              0                         50,000

Changes in assets and liabilities
        Increase in accounts payable and accrued expenses         2,962         (5,000)                        88,606
        Increase in accounts payable and accrued expenses
            -  related party                                      1,553          1,137                         21,217
                                                          -------------  -------------            -------------------
        Net cash used by operating activities                      (825)        (5,200)                      (112,650)
                                                          -------------  -------------            -------------------
FINANCING ACTIVITES
        Proceeds from promissory notes                             (750)         7,000                         61,759
        Proceeds from issuance of common stock                        0              0                         50,900
                                                          -------------  -------------            -------------------
        Net cash provided by financing activites                   (750)         7,000                        112,659
                                                          -------------  -------------            -------------------
INCREASE IN CASH                                                    (75)         1,800                              9

CASH, BEGINNING OF PERIOD                                            84          2,484                              0
                                                          -------------  -------------            -------------------
CASH, END OF PERIOD                                        $          9   $      4,284             $                9
                                                          =============  =============            ===================
</TABLE>


   The accompanying notes are an integral part of these financial statements.


                                       7
<PAGE>


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

STATEMENT OF CASH FLOWS (continued)
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>


                                                                                        FOR THE PERIOD
                                                                                        MARCH 21, 1997
                                                                   THREE MONTHS ENDED (DATE OF INCEPTION)
                                                                       MARCH 31,               TO
                                                                    2008       2007       MARCH 31, 2008
                                                                  --------   --------   -----------------
<S>                                                               <C>        <C>        <C>
Supplemental cash flow information:
        Interest paid                                             $      0   $      0   $              0
                                                                   =======    =======    ===============
        Income taxes paid                                         $      0   $      0   $              0
                                                                   =======    =======    ===============
Noncash investing and financing activities:
        Shares issued to founder for consulting services          $      0   $      0   $             81
                                                                   =======    =======    ===============
        Shares issued for legal services rendered                 $      0   $      0   $            500
                                                                   =======    =======    ===============
</TABLE>


    The accompanying notes are an integral part of these financial statements.


                                       8
<PAGE>

CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


             1.  ORGANIZATION

               Interim  Financial   Information  -  The   unaudited    condensed
              financial statements have been prepared by the  Company   pursuant
              to  the  rules  and   regulations   of the Securities and Exchange
              Commission.    The   information    furnished  herein reflects all
              adjustments   (consisting   of   normal   recurring   accruals and
              adjustments)   which  are,  in  the    opinion   of    management,
              necessary   to   fairly   present  the operating  results  for the
              respective  periods.  Certain information and footnote disclosures
              normally   presented  in annual financial  statements  prepared in
              accordance with  accounting  principles  generally accepted in the
              United  States of America have been omitted pursuant to such rules
              and  regulations.  The  condensed  financial statements  should be
              read   in   conjunction    with   the  description of business and
              management's plan of operations, contained in the Company's Annual
              Report on Form  10-KSB  for the year  ended  December  31,   2007.
              The results of operations  for the three  months  ended March  31,
              2008 are not  necessarily  indicative of the results that may   be
              expected  for the year  ending  December  31,  2008,  or  for  any
              future  period.  In the opinion of  management,  the  accompanying
              financial statements of Centracan, Inc., contains all  adjustments
              necessary to present  fairly the Company's  financial  position as
              of   March   31, 2008   and December 31, 2007,  the  statements of
              operations for the three months ended March 31, 2008 and 2007  and
              cash flows for the three months ended March 31, 2008 and 2007.

           The  results of  operations  for the three  months  ended  March  31,
           2008 and 2007 are not  necessarily indicative of the  results  to  be
           expected for the full year.

           The  accounting  policies  followed by the Company  are set forth  in
           Note 2 to the  Company's  financial statements included in its Annual
           Report on Form 10-KSB for the year ended December 31, 2006.


              DESCRIPTION OF BUSINESS

              Premier  Supplements,  Corp. ("the Company") was  incorporated  on
              March 21, 1997 under the laws of the State of Florida.  On May 15,
              1998 the Company changed its name to Centracan, Inc. The Company's
              operations    have   been  devoted  primarily to  structuring  and
              positioning  itself to take advantage of  opportunities  available
              in the  pharmaceutical  industry.  The  Company intends  to   grow
              through internal development, strategic alliances and acquisitions
              of existing  business.  The Company is a development stage company
              and has had limited activity.

              GOING CONCERN

              The accompanying financial statements have  been   prepared  on  a
              going  concern basis, which contemplates    the    realization  of
              assets    and   the   satisfaction   of   liabilities    in    the
              normal    course    of    business.     As    reflected    in  the
              financial    statements,    development    stage   losses     from

                                       9
<PAGE>

CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


              March 21,  1997   (inception)   to  March  31,   2008   aggregated
              $308,621  and  raise substantial doubt about the Company's ability
              to continue as a going   concern.   The    Company's    cash  flow
              requirements  during  this  period  have been met by contributions
              of capital  and debt financing.  Management's  plans  include  the
              potential  development  of its own  business or merging  with   an
              operating  company.  The Company  anticipates that financing  will
              be required until such time that  the  Company  has  been  able to
              develop  its own  business   or   find   an   appropriate   merger
              candidate.  Currently,  the Company can not determine  when either
              will occur and as such the Company will need to  obtain  financing
              to cover its costs for the  foreseeable  future.  No assurance can
              be given that these  sources of financing  will  continue   to  be
              available. If the Company is unable to generate profits, or unable
              to obtain  additional  funds for its working capital needs, it may
              have to cease operations.

              The  financial  statements  do   not   include   any   adjustments
              relating  to the  recoverability  and classification  of assets or
              liabilities  that might be  necessary should the Company be unable
              to continue as a going concern.

2.                ACCOUNTS PAYABLE AND ACCRUED EXPENSES

                  Accounts payable and accrued expenses at March  31,  2008  and
                  December 31, 2007 consisted of the following:

<TABLE>
<CAPTION>
                                                                   March 31,             December 31,
                                                                      2008                      2007
                                                              --------------            -------------
<S>                                                            <C>                       <C>
Accrued expenses, primarily professional fees                  $     88,606              $    85,645
Account payable - to related parties                                  2,918                    2,918
Accrued interest - to related parties                                18,299                   16,745
                                                              --------------            -------------

Total accounts payable and accrued expenses                    $    109,823              $   105,308
                                                              ==============            =============
</TABLE>

3.                NOTE PAYABLE - RELATED PARTY

                  Through   March   31,   2008,    the  Company  executed  notes
                  aggregating a total of $61,759, which bear interest of 10% per
                  annum..  These notes are convertible  into shares   of  common
                  stock at any time at the  conversion  rate  of $.01 per share.
                  The  value  of the  conversion  feature   was  not  considered
                  material.  A note  payable in the amount of  $24,409,   became
                  due   January    1,  2007    and     accordingly     is     in
                  default,  but   otherwise   is   similar    to     all   other
                  notes that are due on demand.

                                       10
<PAGE>


Item 2.  Management's Discussion and Analysis of Financial Condition
         and Results of Operations.

         Plan of Operation

         We intend to seek to acquire  assets or shares of an  entity   actively
engaged in business that  generates revenues,  in  exchange  for its securities,
although  we have no  particular  acquisitions in mind and have not entered into
any negotiations regarding such an acquisition. None of our officers, directors,
or affiliates have engaged in any  preliminary  contact or  discussions with any
representative  of any other company regarding the possibility of an acquisition
or merger between us and such other company as of the date of this  registration
statement.

         Results of Operation

         We have not had any operating  income since 1998. As of March 31, 2008,
we had an  accumulated deficit of $308,621, comprised of costs mainly associated
with administrative expenses.

         General Business Plan

         Our purpose  is  to   seek,   investigate   and,  if such investigation
warrants,  merge or acquire an interest in business  opportunities  presented to
us  by  persons  or companies that desire to seek the perceived  advantages of a
public  reporting  company.  We will not restrict our  search  to  any  specific
business,  industry,  or geographical location and we  may   participate   in  a
business   venture  of  virtually   any kind or nature.  This  discussion of the
proposed  business  is  purposefully  general   and  is   not    meant   to   be
restrictive  to  our  virtually  unlimited discretion  to search for  and  enter
into  potential  business  opportunities.  We  may  seek a business  opportunity
with entities which have recently  commenced operations, or that wish to utilize
the public  marketplace in order to raise additional  capital in order to expand
into new products or markets,  to develop a new product or service, or for other
corporate    purposes.  We   may   acquire  assets and  establish  wholly  owned
subsidiaries    in   various   businesses  or  acquire  existing  businesses  as
subsidiaries.

         Our executive  officers and directors intend to  contact  a  number  of
broker-dealers,  investment bankers, venture capitalist and other members of the
financial  community  likely to find us a suitable  vehicle capable  of  meeting
the needs of their  clients,  associates  and  contacts.  We cannot be sure that
these efforts will in fact result in our being   presented   with  any   private
companies  seeking to  consummate  a reverse  merger/acquisition transaction. To
date,  we have not been  approached and have not approached any person or entity
with regard to any specific proposed reverse merger/acquisition transaction.

         We anticipate  that the selection of a business opportunity in which to
participate  will be complex  and  extremely  risky.  Due  to  general  economic
conditions, rapid  technological  advances being made  in  some  industries  and
shortages     of     available      capital,    we   believe   that   there  are


                                       11
<PAGE>


numerous  companies seeking the perceived  benefits  of  a  publicly  registered
corporation.  Such perceived benefits may include:

            o  Providing increased liquidity for  its  existing  principals  and
               stockholders.
            o  Facilitating or improving the terms by  which  additional  equity
               financing may be sought.
            o  Creating an "alternative currency" (i.e., publicly traded shares)
               that can be used for acquisitions.
            o  Providing increased liquidity  for  incentive  stock option plans
               or similar employee  benefit plans in order to attract and retain
               key employees.
            o  Providing   an   exit   mechanism  or retirement strategy for its
               owners.

         Potentially,  available  business  opportunities   may  occur  in  many
different  industries  and at various stages of development,  all of which  will
make   the  task  of  comparative   investigation and  analysis of such business
opportunities extremely difficult and complex.

         We  have,  and will  continue  to  have,  no  capital  with  which   to
provide  the  owners  of  business opportunities  with any  significant  cash or
other assets which going public  through  an  initial   public   offering  would
provide.  There is,  however,  significant   other   benefits  to  going  public
through a merger or acquisition transaction  with a blank check company such  as
ours, as opposed to an initial public  offering,  which management believes will
make  us   attractive   to a potential merger or acquisition candidate, such as:

             o  The costs are significantly less than the costs required for  an
                initial public offering.
             o  The  time  required   completing   a   merger   or   acquisition
                transaction  with a blank  check  company  is considerably  less
                than for an initial public offering.
             o  Additional  risks are involved in an initial public  offering in
                that the initial  public  offering may be  withdrawn  due  to an
                unstable market condition even after most of the up-front  costs
                have been expended.
             o  Initial  public  offerings  generally  require greater attention
                from top management.
             o  While an initial  public  offering  requires  a business to have
                a  relatively  long and stable  earnings history, the lack of an
                earnings  history  does  not  normally  keep a  private  company
                from completing a merger or acquisition transaction with a blank
                check company.
             o  The private company does not require an underwriter.
             o  There is less dilution of ownership control.

         The owners  of  the  business   opportunities  will,   however,   incur
significant legal and accounting costs in connection  with  acquisition   of   a
business  opportunity,  including the costs of preparing  Form 8-K's or  10-K's,
agreements   and   related   reports    and   documents.   The   Exchange    Act
specifically  requires  that any  merger or acquisition  candidate  comply  with
all  applicable  reporting  requirements,  which   include   providing   audited
financial  statements  to be included  within the numerous  filings  relevant to
complying  with the Exchange  Act. Nevertheless, our officers and directors have
not conducted  market research and are not aware of statistical data that  would
support the  perceived  benefits of a merger or  acquisition transaction for the
owners of a business opportunity.

         Management   believes   that  any   transaction,   whether  a merger or
acquisition  with a private  company will require us  to  issue  a   substantial
majority       of      our      common       stock   to  the  owners   of    the


                                       12
<PAGE>


private  company   in   exchange   for  all of their privately held shares.  The
transaction will effectively result in the owners and management of the  private
business  acquiring  actual or  effective  operating  control of us,  with   our
existing  stockholders continuing only as minority  passive investors. This type
of   transaction   is   popularly   known   as   a  "reverse merger" or "reverse
acquisition."  It is referred to as a reverse  merger  or  reverse   acquisition
because, although for legal purposes, we will acquire the private  company,  the
transaction can be viewed as if we have been acquired by the private company due
to the fact that the former owners of the private company will own a substantial
majority of our common stock after the transaction.

         The Securities and Exchange Commission  considers this type of  reverse
merger/acquisition  transaction to be a capital transaction in substance, rather
than a business  combination.  That is, the  transaction  will be equivalent  to
the  issuance  of stock  by the  private  company for our net  monetary  assets,
accompanied    by    a    recapitalization.   As  a   result,  our  post-reverse
merger/acquisition  comparative  historical  financial statements will be  those
of the private company,  with appropriate  footnote disclosure  concerning   the
changes in the capital structure of the private company effected at the  reverse
merger/acquisition transaction date.

         Evaluation of Acquisition Opportunities

         We intend to request  that  we  be  provided  with  written   materials
regarding   the   private   company,    prior   to    considering    a   reverse
merger/acquisition transaction with that company. We will request such items as:

            o  a description of products, service and company history;
            o  management resumes;
            o  audited financial information;
            o  available projections with related assumptions  upon  which  they
               are based;
            o  an explanation of proprietary products and services;
            o  evidence   of   existing  patents, trademarks or service marks or
               rights thereto;
            o  present and proposed forms of compensation to management;
            o  a description of transactions between the privately-held  company
               and its affiliates during relevant prior periods;
            o  a description of present and required facilities;
            o  an analysis of risks and competitive conditions;
            o  a financial plan of operation and estimated capital requirements;
               and
            o  other information deemed relevant.

         We   will    endeavor   to   personally  meet with  management  and key
personnel of companies  that are serious candidates for   concluding  a  reverse
merger or  acquisition.  We will also attempt to obtain   independent   analysis
or verification of certain information provided,  check references of management
and key personnel,  and take other reasonable  investigative  measures,  to  the
extent   of   our    limited    financial    resources.  We will not  acquire or
merge with any company for which  current  audited  financial  statements cannot
be obtained  prior to closing the  proposed   transaction.   Requiring   audited
financial  statements  prior  to  closing  will  ensure  that  we  can  meet our
regulatory filing obligations for such transactions at the time of closing.

         We  intend  to  take  into   consideration  the following   factor when
analyzing a company for its potential as a reverse merger/acquisition candidate:

            o  Potential for growth, indicated by  new  technology,  anticipated
               market expansion or new products;



                                       13
<PAGE>




            o  Competitive  position  as  compared to other companies of similar
               size and experience within the privately-held company's  industry
               segment as well as within the industry as a whole;
            o  Strength   and   diversity  of  management,  either  in  place or
               scheduled for recruitment;
            o  Capital  requirements  and  anticipated  availability of required
               funds, to be provided by us or from operations, through  the sale
               of   additional   securities,   through joint ventures or similar
               arrangements or from other sources;
            o  The   extent  to which the business of the privately-held company
               can be advanced;
            o  The regulatory environment within the  privately-held   company's
               industry;
            o  The market performance of equity securities of similarly situated
               companies in the  privately-held company's industry; and
            o  Reputation of owners,  principals  and/or  managers for complying
               with and not violating  federal  and/or state securities laws.

         The time,  effort and  expense required to  evaluate a private  company
for a reverse  merger/acquisition transaction  with us and to effectuate  such a
transaction  cannot be predicted with any degree of accuracy. We do not have any
full-time  employees  and our executive officers and directors, are not required
to devote any specific amount of time to our business.

         We do not foresee  entering  into a merger or  acquisition  transaction
with any business with which our officers or directors are currently affiliated.
Should we  determine  in the future,  contrary  to  foregoing expectations  that
a transaction  with an affiliate would be in our  best  interests,  Florida  law
generally  permits us to enter into such a transaction.

Item 4T. Controls and Procedures

         This   quarterly  report   does   not  include a report of management's
assessment  regarding  internal  control over  financial   reporting  due  to  a
transition  period  established  by  rules  of the   Securities   and   Exchange
Commission for newly public companies.

                                   PART II

Item 1.  Legal Proceedings.

         None.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

         None.

Item 3.  Defaults Upon Senior Securities.

         A  promissory  note  payable  in  the  amount  of  $24,409   became due
January 1, 2007 and  accordingly  is in default.

Item 4. Submission of Matters to a Vote of Security Holders.

         None.



                                       14
<PAGE>




Item 5. Other Information.

         None.

Item 6.  Exhibits.

Index to Exhibits.

3.1*              Articles of Incorporation

3.2*              Amendment No. 1 to Articles of Incorporation

3.3*              Amendment No. 2 to Articles of Incorporation

3.4*              By-laws

31.1              Rule 13(a) -- 14(a)/15(d) -- 14(a)  Certification   (Principal
                  Executive Officer)

31.2              Rule 13(a) -- 14(a)/15(d) -- 14(a)  Certification   (Principal
                  Financial Officer)

32.1              Section 1350 Certification (Principal Executive Officer)

32.2              Section 1350 Certification (Principal Financial Officer)

         *  Incorporated    by    Reference    to   the  Company's  Registration
Statement on Form 10-SB filed on November 13, 2007.


                                    SIGNATURES

         Pursuant    to   the    requirements   of  Section  13 or  15(d) of the
Securities  Exchange  Act of  1934,  the registrant has duly caused this  report
to be signed on its behalf by the undersigned, thereunto duly authorized.

                                     CENTRACAN INCORPORATED

Dated: May 29, 2008                  By: /s/Jerome Goubeaux
                                        ---------------------------------------
                                           Jerome Goubeaux,
                                           Chief Executive Officer and Director



                                       15